312 related articles for article (PubMed ID: 36766357)
41. Histone deacetylase inhibition: an important mechanism in the treatment of lymphoma.
Guo SQ; Zhang YZ
Cancer Biol Med; 2012 Jun; 9(2):85-9. PubMed ID: 23691460
[TBL] [Abstract][Full Text] [Related]
42. Biological and clinical significance of epigenetic alterations in B-cell lymphomas.
Ennishi D
Int J Hematol; 2022 Dec; 116(6):821-827. PubMed ID: 36208393
[TBL] [Abstract][Full Text] [Related]
43. MicroRNAs as Biomarkers in Canine Osteosarcoma: A New Future?
Gourbault O; Llobat L
Vet Sci; 2020 Sep; 7(4):. PubMed ID: 33008041
[TBL] [Abstract][Full Text] [Related]
44. [Malignant lymphoma].
Kato H; Kinoshita T
Rinsho Ketsueki; 2016 Mar; 57(3):249-59. PubMed ID: 27076235
[TBL] [Abstract][Full Text] [Related]
45. Clinical and Clinical Pathological Presentation of 310 Dogs Affected by Lymphoma with Aberrant Antigen Expression Identified via Flow Cytometry.
Celant E; Marconato L; Stefanello D; Moretti P; Aresu L; Comazzi S; Martini V
Vet Sci; 2022 Apr; 9(4):. PubMed ID: 35448684
[TBL] [Abstract][Full Text] [Related]
46. Hematological and biochemical profiles of canine CD45
Sánchez-Solé R; Mosquillo F; Jark P; Breijo M; Pessina P
Open Vet J; 2021; 11(4):734-746. PubMed ID: 35070871
[TBL] [Abstract][Full Text] [Related]
47. The Comparative Diagnostic Features of Canine and Human Lymphoma.
Seelig DM; Avery AC; Ehrhart EJ; Linden MA
Vet Sci; 2016 Jun; 3(2):. PubMed ID: 28435836
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Options for Aggressive T-Cell Lymphomas.
Lue JK; Kress A; Amengual JE
Curr Hematol Malig Rep; 2017 Aug; 12(4):269-281. PubMed ID: 28573497
[TBL] [Abstract][Full Text] [Related]
49. A potential therapeutic application of SET/I2PP2A inhibitor OP449 for canine T-cell lymphoma.
Fujiwara N; Kawasaki H; Yabe R; Christensen DJ; Vitek MP; Mizuno T; Sato K; Ohama T
J Vet Med Sci; 2013; 75(3):349-54. PubMed ID: 23131782
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors for treated canine malignant lymphoma.
Kiupel M; Teske E; Bostock D
Vet Pathol; 1999 Jul; 36(4):292-300. PubMed ID: 10421095
[TBL] [Abstract][Full Text] [Related]
51. JARID1-targeted histone H3 demethylase inhibitors exhibit anti-proliferative activity and overcome cisplatin resistance in canine oral melanoma cell lines.
Tobin SJ; Chang H; Kent MS; Davies AE
Vet Comp Oncol; 2021 Sep; 19(3):518-528. PubMed ID: 33715247
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic drug discovery for Alzheimer's disease.
Cacabelos R; Torrellas C
Expert Opin Drug Discov; 2014 Sep; 9(9):1059-86. PubMed ID: 24989365
[TBL] [Abstract][Full Text] [Related]
53. The diagnostic assessment of canine lymphoma: implications for treatment.
Bienzle D; Vernau W
Clin Lab Med; 2011 Mar; 31(1):21-39. PubMed ID: 21295720
[TBL] [Abstract][Full Text] [Related]
54. Minimal residual disease in canine lymphoma: An objective marker to assess tumour cell burden in remission.
Sato M; Yamazaki J; Goto-Koshino Y; Setoguchi A; Takahashi M; Baba K; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2016 Sep; 215():38-42. PubMed ID: 27339366
[TBL] [Abstract][Full Text] [Related]
55. Impact of serum C-reactive protein level as a biomarker of cancer dissemination in canine lymphoid neoplasia.
Manachai N; Umnuayyonvaree D; Punyathi P; Rungsipipat A; Rattanapinyopituk K
Vet World; 2022 Dec; 15(12):2810-2815. PubMed ID: 36718344
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic alterations in canine mammary cancer.
Borges BDN
Genet Mol Biol; 2022; 45(3 Suppl 1):e20220131. PubMed ID: 36279498
[TBL] [Abstract][Full Text] [Related]
57. Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?
Lue JK; Amengual JE; O'Connor OA
Curr Oncol Rep; 2015 Sep; 17(9):40. PubMed ID: 26141799
[TBL] [Abstract][Full Text] [Related]
58. Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?
Richards KL; Suter SE
Immunol Rev; 2015 Jan; 263(1):173-91. PubMed ID: 25510277
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic drugs for cancer treatment and prevention: mechanisms of action.
Yu XD; Guo ZS
Biomol Concepts; 2010 Oct; 1(3-4):239-51. PubMed ID: 25962000
[TBL] [Abstract][Full Text] [Related]
60. Investigation of proteomic profiles in canine lymphoma using tandem mass tag-based quantitative proteomics approach.
Fonghem P; Pisitkun T; Rattanapinyopituk K; Sirivisoot S; Rungsipipat A
Vet World; 2022 May; 15(5):1333-1340. PubMed ID: 35765478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
